Theravance Biopharma, Inc. (NASDAQ:TBPH) Q2 2025 Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q2 2025 Earnings Call Transcript August 12, 2025

Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $1.08, expectations were $-0.14.

Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Biopharma Second Quarter 2025 Conference Call. [Operator Instructions] Also, today’s conference is being recorded. And now I would like to turn the call over to Rick Winningham, Chief Executive Officer....